Bualat, Baby Girl .
HRN: 21-99-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/20/2022
11/26/2022
IVT
20mg
OD
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes